First-Line, Fixed-Duration Nivolumab Plus Ipilimumab Followed by Nivolumab in Clinically Diverse Patient Populations With Unresectable Stage III or IV Melanoma: CheckMate 401 Patients who underwent ...
DURHAM, NC – A nationwide analysis of PCI suggests there is wide variability in the practice of blood transfusions and that patients who received blood transfusions fared significantly worse following ...
Anlotinib versus placebo as adjuvant therapy for completely resected high-grade soft tissue sarcomas: Interim results of a phase 2, double-blinded, randomized controlled trial. This is an ASCO Meeting ...
Percutaneous coronary interventions are commonly performed as the accepted practice for the treatment of coronary artery disease. Owing to its invasive nature in conjunction with the use of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback